No Data
No Data
TuHURA Biosciences Analyst Ratings
Rodman & Renshaw Initiates TuHURA Biosciences(HURA.US) With Buy Rating, Announces Target Price $11
TuHURA Biosciences Initiated With a Buy at Rodman & Renshaw
Key Deals for the Week: Patterson, Hershey & Mondelez, AIG & Nippon and More
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating TuHURA Biosciences, Inc. Merger
Express News | The Cash Component Of The Aggregate Merger Consideration Will Be A Base Cash Amount Of $9,005,000 (Consisting Of A Value Of $15M Minus The $5,995,000 Advanced To Kineta Under The Exclusivity And Right Of First Offer Agreement)